Short Interest in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Decreases By 73.5%

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the target of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 3,500 shares, a decrease of 73.5% from the December 31st total of 13,200 shares. Based on an average daily volume of 33,700 shares, the short-interest ratio is presently 0.1 days.

Reviva Pharmaceuticals Stock Performance

Shares of NASDAQ RVPHW traded down $0.02 during midday trading on Tuesday, reaching $0.18. 2,469 shares of the company were exchanged, compared to its average volume of 36,651. Reviva Pharmaceuticals has a one year low of $0.07 and a one year high of $1.11. The stock’s 50-day moving average price is $0.22 and its 200-day moving average price is $0.17.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.